ClinicalTrials.gov
ClinicalTrials.gov Menu

Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01228812
Recruitment Status : Completed
First Posted : October 27, 2010
Last Update Posted : October 27, 2010
Sponsor:
Information provided by:
University of Lausanne

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of the study is to compare physical activity behaviour of rheumatoid arthritis patients with healthy matched controls.

Condition or disease
Rheumatoid Arthritis

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: An Observational Study of Physical Activity Behavior of Swiss Rheumatoid Arthritis Patients and Healthy Matched Controls
Study Start Date : April 2010
Actual Primary Completion Date : September 2010
Actual Study Completion Date : September 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
RA patients
Patients with Rheumatoid Arthritis
Healthy subjects
Healthy subjects matched for age and sex


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Physical activity
    PAFQ


Secondary Outcome Measures :
  1. Functional status
    HAQ

  2. Pain
    VAS

  3. Fatigue
    VAS

  4. Disease activity
    DAS 28


Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Patients from the RA patients group will be selected in the Rheumatology Department of the Centre Hospitalier universitaire Vaudois in Lausanne. Healthy matched controls will be randomly selected from a cohort study conducted in Lausanne.
Criteria

Inclusion Criteria (RA patients):

  • Rheumatoid arthritis
  • Functional classes I, II and III
  • Age 40 to 80 years
  • Stable disease activity
  • Stable DMARDS last 3 months

Exclusion Criteria (RA patients):

  • Functional classes IV
  • Inflammatory flare
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01228812


Locations
Switzerland
Centre Hospitalier Universitaire Vaudois, Département de l'Appareil Locomoteur
Lausanne, Switzerland
Sponsors and Collaborators
University of Lausanne
Investigators
Study Director: Alexander KL So, PhD, FRCP Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Principal Investigator: Yves Henchoz, PhD Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Study Chair: Jean Dudler, PD, MER Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Study Chair: François Bastardot, MD Etude CoLaus, Centre Hospitalier Universitaire Vaudois, Lausanne
Study Chair: Peter Vollenweider, MD Etude CoLaus, Centre Hospitalier Universitaire Vaudois, Lausanne
Study Chair: Idris Guessous, MD Unité d'Epidémiologie Populationnelle, Département de médecine communautaire et de premier recours, Hôpitaux Universitaires de Genève
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT01228812     History of Changes
Other Study ID Numbers: PR_AP
First Posted: October 27, 2010    Key Record Dates
Last Update Posted: October 27, 2010
Last Verified: October 2010

Keywords provided by University of Lausanne:
Rheumatoid arthritis, physical activity

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
 Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases